Gene Therapy/Neuroregeneration

 

Genomics is becoming an important component not only of family counseling related to glaucoma, but also of therapeutic care. Isolation of genetic material responsible for morphological changes in the trabecular meshwork matrix has already been achieved. The TIGR/MYOC gene variant mt-1 test for primary open angle glaucoma is now available (InSite Vision, http://www.insitevision.com), and there are other diagnostic kits that can assess the genes associated with other forms of glaucoma.

Figure 21. Insite Vision’s Ocugene genetic glaucoma test. (Image from http://www.insitevision.com/wt/page/ocugene)